Literature DB >> 22752333

Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.

Cristóbal León1, Sergio Ruiz-Santana, Pedro Saavedra, Carmen Castro, Alejandro Ubeda, Ana Loza, Estrella Martín-Mazuelos, Armando Blanco, Vicente Jerez, Josep Ballús, Luis Alvarez-Rocha, Aránzazu Utande-Vázquez, Osvaldo Fariñas.   

Abstract

PURPOSE: To assess the value of (1→3)-β-D: -glucan (BDG), Candida albicans germ tube antibody (CAGTA), C-reactive protein (CRP), and procalcitonin (PCT) levels for the diagnosis of invasive candidiasis (IC) and for differentiating Candida spp. colonization from infection in ICU patients with severe abdominal conditions (SAC).
METHODS: Prospective study of 176 non-neutropenic patients, with SAC at ICU admission, and expected to stay at least 7 days. Surveillance cultures and BDG, CAGTA, CRP, and PCT levels were performed on the third day of ICU stay and twice a week for four consecutive weeks. Patients were grouped into invasive candidiasis (IC), Candida colonization, and neither colonized/nor infected. The classification and regression tree (CART) analysis was used to predict IC in colonized patients. The discriminatory ability of the obtained prediction rule was assessed by the area under the ROC curve (AUC).
RESULTS: The probabilities of IC were 59.3 % for the terminal node of BDG greater than 259 pg/mL and 30.8 % for BDG less than 259 pg/mL and CAGTA positivity, whereas there was a 93.9 % probability in predicting the absence of IC for BDG less than 259 pg/mL and negative CAGTA. Using a cutoff of 30 % for IC probability, the prediction rule showed 90.3 % sensitivity, 54.8 % specificity, 42.4 % positive predictive value, and 93.9 % negative predictive value with an AUC of 0.78 (95 % confidence interval 0.76-0.81). Significant differences in CRP (p = 0.411) and PCT (p = 0.179) among the studied groups were not found.
CONCLUSIONS: BDG with a positive test for CAGTA accurately differentiated Candida colonization from IC in patients with SAC, whereas CRP and PCT did not.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752333     DOI: 10.1007/s00134-012-2616-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  30 in total

1.  Does ampicillin-sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections.

Authors:  Gokhan Metan; Cigdem Agkus; A Nedret Koc; Ferhan Elmali; Malcolm A Finkelman
Journal:  Mycoses       Date:  2011-11-01       Impact factor: 4.377

2.  β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.

Authors:  Drosos E Karageorgopoulos; Evridiki K Vouloumanou; Fotinie Ntziora; Argyris Michalopoulos; Petros I Rafailidis; Matthew E Falagas
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

3.  Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections.

Authors:  O Albert; D Toubas; C Strady; J Cousson; C Delmas; V Vernet; I Villena
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-10       Impact factor: 3.267

4.  Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.

Authors:  Sophia Koo; Julie M Bryar; John H Page; Lindsey R Baden; Francisco M Marty
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

5.  Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

Authors:  Cristóbal León; Sergio Ruiz-Santana; Pedro Saavedra; Beatriz Galván; Armando Blanco; Carmen Castro; Carina Balasini; Aránzazu Utande-Vázquez; Francisco J González de Molina; Miguel A Blasco-Navalproto; Maria J López; Pierre Emmanuel Charles; Estrella Martín; María Adela Hernández-Viera
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

6.  [Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis].

Authors:  María Dolores Moragues; Natalia Ortiz; José Ramón Iruretagoyena; Juan Carlos García-Ruiz; Elena Amutio; Almudena Rojas; Joaquín Mendoza; Guillermo Quindós; José Pontón-San Emeterio
Journal:  Enferm Infecc Microbiol Clin       Date:  2004-02       Impact factor: 1.731

7.  Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients.

Authors:  R Zaragoza; J Pemán; G Quindós; J R Iruretagoyena; M S Cuétara; P Ramírez; M D Gómez; J J Camarena; A Viudes; J Pontón
Journal:  Clin Microbiol Infect       Date:  2009-05-11       Impact factor: 8.067

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 9.  Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.

Authors:  Philipp Schuetz; Werner Albrich; Beat Mueller
Journal:  BMC Med       Date:  2011-09-22       Impact factor: 8.775

10.  Diagnosis of invasive candidiasis in the ICU.

Authors:  Philippe Eggimann; Jacques Bille; Oscar Marchetti
Journal:  Ann Intensive Care       Date:  2011-09-01       Impact factor: 6.925

View more
  33 in total

Review 1.  [Strategies for antifungal treatment failure in intensive care units].

Authors:  C Arens; M Bernhard; C Koch; A Heininger; D Störzinger; T Hoppe-Tichy; M Hecker; B Grabein; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2015-09       Impact factor: 1.041

2.  Comparison of Performance Characteristics of Aspergillus PCR in Testing a Range of Blood-Based Samples in Accordance with International Methodological Recommendations.

Authors:  Jan Springer; P Lewis White; Shanna Hamilton; Denise Michel; Rosemary A Barnes; Hermann Einsele; Juergen Löffler
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948

3.  Quick Detection of FKS1 Mutations Responsible for Clinical Echinocandin Resistance in Candida albicans.

Authors:  Catiana Dudiuk; Soledad Gamarra; Cristina Jimenez-Ortigosa; Florencia Leonardelli; Daiana Macedo; David S Perlin; Guillermo Garcia-Effron
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

4.  What's new in antimicrobial use and resistance in critically ill patients?

Authors:  Matteo Bassetti; David P Nicolau; Thierry Calandra
Journal:  Intensive Care Med       Date:  2013-12-18       Impact factor: 17.440

5.  Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.

Authors:  Philippe Montravers; Herve Dupont; Philippe Eggimann
Journal:  Intensive Care Med       Date:  2013-10-24       Impact factor: 17.440

6.  Intra-abdominal candidiasis: it's still a long way to get unquestionable data.

Authors:  Philippe Montravers; Olivier Leroy; Christian Eckmann
Journal:  Intensive Care Med       Date:  2015-06-19       Impact factor: 17.440

7.  The most recent concepts for the management of bacterial and fungal infections in ICU.

Authors:  Matteo Bassetti; Garyfallia Poulakou; Marin H Kollef
Journal:  Intensive Care Med       Date:  2018-10-06       Impact factor: 17.440

8.  Evaluation of a commercially developed semiautomated PCR-surface-enhanced raman scattering assay for diagnosis of invasive fungal disease.

Authors:  P Lewis White; Samantha J Hibbitts; Michael D Perry; Julie Green; Emma Stirling; Luke Woodford; Graeme McNay; Ross Stevenson; Rosemary A Barnes
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

Review 9.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

10.  Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study).

Authors:  Martin Albert; David Williamson; John Muscedere; Francois Lauzier; Coleman Rotstein; Salmaan Kanji; Xuran Jiang; Mark Hall; Daren Heyland
Journal:  Intensive Care Med       Date:  2014-07-01       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.